ZHANG Cun, LIU Ying, XIAO Yong-qing. Strengthening Production Management of Chinese Medicinal Materials and Stabilizing Quality of Traditional Chinese Medicine Products[J]. Chinese journal of experimental traditional medical formulae, 2017, 23(15): 1-4.
DOI:
ZHANG Cun, LIU Ying, XIAO Yong-qing. Strengthening Production Management of Chinese Medicinal Materials and Stabilizing Quality of Traditional Chinese Medicine Products[J]. Chinese journal of experimental traditional medical formulae, 2017, 23(15): 1-4. DOI: 10.13422/j.cnki.syfjx.2017150001.
Strengthening Production Management of Chinese Medicinal Materials and Stabilizing Quality of Traditional Chinese Medicine Products
According to the analysis of the actual situation of the cultivation of Chinese medicinal materials and its quality evaluation
the authors exhibited the suggestion of the cultivation
processing and production pattern of Chinese medicinal materials.Chinese herbal medicine should not continue to be treated as Chinese agricultural and sideline products and its cultivation should be managed by the department of agriculture management;as the raw materials of traditional Chinese medicine(TCM) products
its cultivation should be managed by the department of TCM.Different quality management modes of Chinese herbal medicine should be established to meet different usage as raw materials of kinds of products.The model of imitation of the wild ecological construction should be advocated.The cultivated organisms
such as to change the original natural environment of Chinese herbs
which could make the secondary metabolites variation
cannot be called Chinese herbal medicine
it can only be called natural products.The natural products as raw materials for the production of drugs can only be called natural drugs instead of Chinese medicine.Standard library of Chinese slices should be set up.
Meta-analysis and Grade Evidence Evaluation of Qi-reinforcing and Blood-activating/ Stasis-expelling Chinese Patent Medicines in Treatment of Coronary Microvascular Disease
Interpretation of Reporting Items for Practice Guidelines in Healthcare for Chinese Patent Medicines (RIGHT for CPM)
Clinical Comprehensive Evaluation of Chinese Patent Medicines in Treatment of Stable Angina Pectoris with Qi Stagnation and Blood Stasis
GRADE Clinical Study Evidence Evaluation and Expert Consensus on Antihypertensive Chinese Patent Medicines Combined with Western Medicines for Treatment of Hypertension
Evaluation of GRADE Clinical Research Evidence of Chinese Patent Medicine Combined with Western Medicine in Treatment of Hypertension with Dyslipidemia
Related Author
CHEN Jiaping
SHANG Juju
LIU Hongxu
LI Xiang
LAI Xiaolei
ZHOU Huiwen
WANG Liaoyao
PAN Hejing
Related Institution
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Center for Evidence-based Medicine, Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences
School of Basic Medical Sciences, Zhejiang Chinese Medical University
The Affiliated Hospital of Traditional Chinese Medicine, Xinjiang Medical University